Melatonin in autoimmune disease
Abstract:
Methods for treating, or reducing risk of developing, seasonal worsening of multiple sclerosis (MS) in a subject who has MS, comprising administering a melatonin agonist to a subject.
Public/Granted literature
Information query
Patent Agency Ranking
0/0